November 6, 2019 to November 10, 2019

Oral presentation:

  • Concurrent Session 312: NK Cells: From Basic Science to Clinical Application “Basic Science” presented by Eric Vivier, DVM, PhD, Innate Pharma

    Saturday, November 9 | 5:15 pm

 

Poster presentations:

  • IPH5301, a CD73 blocking antibody targeting the adenosine immunosuppressive pathway for cancer immunotherapy, Poster P323

    Friday November 8 | 12:30 - 2 pm & 6:30 – 8 pm

     

  • IPH5201, a blocking antibody targeting the CD39 immunosuppressive pathway, unleashes immune responses in combination with cancer therapies, Poster P488

    Saturday November 9 | 12:35 - 2:05 pm & 7 - 8:30 pm

     

  • IPH5401 anti-human C5aR antibody targets suppressive myeloid cells in the TME, Poster P268

    Saturday November 9 | 12:35 - 2:05 pm & 7 - 8:30 pm

     

  • Multifunctional natural killer cell engagers targeting NKp46 trigger protective tumor immunity, Poster P776

    Saturday November 9 | 12:35 - 2:05 pm & 7 - 8:30 pm

 

Visit SITC's website